Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1771 record(s)

Req # A-2020-000597

Adverse Reaction Reports (AERs). Report numbers: 000909745, E2B_03157562, E2B_02749235, E2B_02699021.

Organization: Health Canada

42 page(s)
October 2020

Req # A-2020-000611

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03166078.

Organization: Health Canada

130 page(s)
October 2020

Req # A-2020-000614

Adverse Reaction Report (AER). Report number: E2B_03154134.

Organization: Health Canada

10 page(s)
October 2020

Req # A-2020-000633

Adverse Reaction Reports (AERs). Report numbers: E2B_02351915, 000722617, E2B_02400241, 000725407, E2B_02424538, 000725458, E2B_02452806, E2B_02481318, E2B_02509973.

Organization: Health Canada

240 page(s)
October 2020

Req # A-2020-000668

Adverse Reaction Report (AER) for PANTOPRAZOLE SODIUM. Report number: E2B_03054315.

Organization: Health Canada

17 page(s)
October 2020

Req # A-2020-000708

Adverse Reaction Report (AER). Report number: 00663509.

Organization: Health Canada

7 page(s)
October 2020

Req # A-2020-000711

Adverse Reaction Reports (AERs). Report numbers: E2B_02577313, E2B_02577319, E2B_02579272, E2B_02579273, E2B_02579292, E2B_02579339, E2B_02579757, E2B_02580619, E2B_02583215, E2B_02637969.

Organization: Health Canada

119 page(s)
October 2020

Req # A-2020-000713

Adverse Reaction Reports (AERs). Report numbers: 000675962, 000716878, 000726488, 000726491, 000730027, E2B_02554038, E2B_02559687, E2B_02564712, E2B_02567289, E2B_02567655.

Organization: Health Canada

87 page(s)
October 2020

Req # A-2020-000727

Adverse Reaction Reports (AERs). Report numbers: E2B_02558071, E2B_02575168, E2B_02575844, E2B_02586575, E2B_02755438 E2B_02801300, 000731411, 000731008, E2B_02828565, E2B_02823147, E2B_02836594.

Organization: Health Canada

173 page(s)
October 2020

Req # A-2020-000748

Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03021475.

Organization: Health Canada

20 page(s)
October 2020
Date modified: